Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionJacobi Capital Management LLC
Latest Disclosed Ownership12,712 shares
Latest Disclosed Value $ 4,472,760
Jacobi Capital Management LLC reports 2.11% decrease in ownership of AMGN / Amgen Inc.

On May 14, 2026 - Jacobi Capital Management LLC filed a 13F-HR form disclosing ownership of 12,712 shares of Amgen Inc. (MX:AMGN) valued at $4,472,760 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 12,986 shares of Amgen Inc.. This represents a change in shares of -2.11% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AMGEN COM 031162100 12,712 -274 -2.11 4,473 5.22 0.2499
2026-02-13 2025-12-31 13F AMGEN COM 031162100 12,986 -359 -2.69 4,250 12.88 0.2463
2025-11-07 2025-09-30 13F AMGEN COM 031162100 13,345 1,228 10.13 3,766 11.29 0.2293
2025-08-12 2025-06-30 13F AMGEN COM 031162100 12,117 793 7.00 3,383 -4.11 0.2246
2025-05-27 2025-03-31 13F AMGEN COM 031162100 11,324 116 1.03 3,528 20.78 0.2602
2025-02-05 2024-12-31 13F AMGEN COM 031162100 11,208 463 4.31 2,921 -15.63 0.2182
2024-11-14 2024-09-30 13F AMGEN COM 031162100 10,745 168 1.59 3,462 4.78 0.2617
2024-08-09 2024-06-30 13F AMGEN COM 031162100 10,577 -60 -0.56 3,305 9.26 0.2869
2024-05-10 2024-03-31 13F AMGEN COM 031162100 10,637 737 7.44 3,024 6.07 0.2795
2024-02-14 2023-12-31 13F AMGEN COM 031162100 9,900 -686 -6.48 2,851 0.25 0.2924
2023-11-13 2023-09-30 13F AMGEN COM 031162100 10,586 136 1.30 2,845 22.59 0.3216
2023-08-08 2023-06-30 13F AMGEN COM 031162100 10,450 -2,888 -21.65 2,320 -28.04 0.2595
2023-05-05 2023-03-31 13F AMGEN COM 031162100 13,338 1,400 11.73 3,225 2.84 0.3826
2023-02-13 2022-12-31 13F AMGEN COM 031162100 11,938 -132 -1.09 3,136 15.21 0.3921
2022-11-09 2022-09-30 13F AMGEN COM 031162100 12,070 -54 -0.45 2,721 -7.76 0.3725
2022-08-05 2022-06-30 13F AMGEN COM 031162100 12,124 -792 -6.13 2,950 -5.57 0.3924
2022-05-06 2022-03-31 13F AMGEN COM 031162100 12,916 75 0.58 3,124 8.13 0.3733
2022-02-14 2021-12-31 13F AMGEN COM 031162100 12,841 629 5.15 2,889 11.24 0.3443
2021-11-15 2021-09-30 13F AMGEN COM 031162100 12,212 1,185 10.75 2,597 -3.39 0.3302
2021-08-12 2021-06-30 13F AMGEN COM 031162100 11,027 22 0.20 2,688 -1.83 0.3552
2021-05-11 2021-03-31 13F AMGEN COM 031162100 11,005 382 3.60 2,738 7.97 0.4041
2021-02-08 2020-12-31 13F AMGEN COM 031162100 10,623 578 5.75 2,536 2.71 0.4003
2020-10-30 2020-09-30 13F AMGEN COM 031162100 10,045 -222 -2.16 2,469 -0.72 0.4332
2020-08-04 2020-06-30 13F/A-1 AMGEN COM 031162100 10,267 119 1.17 2,487 16.38 0.4650
2020-07-27 2020-06-30 13F AMGEN COM 031162100 10,266 118 2,487 464,962.3655
2020-04-24 2020-03-31 13F AMGEN COM 031162100 10,148 -540 -5.05 2,137 -15.43 0.4593
2020-02-03 2019-12-31 13F AMGEN COM 031162100 10,688 -693 -6.09 2,527 13.17 0.4610
2019-11-12 2019-09-30 13F AMGEN COM 031162100 11,381 29 0.26 2,233 7.05 0.4418
2019-08-07 2019-06-30 13F AMGEN COM 031162100 11,352 4,309 61.18 2,086 55.90 0.4238
2019-05-13 2019-03-31 13F AMGEN COM 031162100 7,043 -2,410 -25.49 1,338 -27.28 0.3416
2019-02-11 2018-12-31 13F AMGEN COM 031162100 9,453 110 1.18 1,840 -5.01 0.5031
2018-11-14 2018-09-30 13F AMGEN COM 031162100 9,343 3 0.03 1,937 12.35 0.5178
2018-08-14 2018-06-30 13F AMGEN COM 031162100 9,340 342 3.80 1,724 15.39 0.4982
2018-05-03 2018-03-31 13F AMGEN COM 031162100 8,998 -759 -7.78 1,494 -15.21 0.4479
2018-02-05 2017-12-31 13F AMGEN COM 031162100 9,757 2,396 32.55 1,762 29.08 0.5703
2017-11-02 2017-09-30 13F AMGEN COM 031162100 7,361 5,550 306.46 1,365 337.50 0.4627
2017-08-10 2017-06-30 13F AMGEN COM 031162100 1,811 1,467 426.45 312 457.14 0.1207
2017-05-26 2017-03-31 13F AMGEN COM 031162100 344 0 0.00 56 3.70 0.0287
2017-02-08 2016-12-31 13F AMGEN COM 031162100 344 100 40.98 54 31.71 0.0330
2016-11-14 2016-09-30 13F AMGEN COM 031162100 244 0 0.00 41 7.89 0.0194
2016-11-14 2016-06-30 13F AMGEN COM 031162100 244 244 38 0.0190
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.